Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.86 trillion, total revenue of $4.7 trillion and a weighted average PE ratio of 49.19.
Market Cap
9.86T
Revenue
4.7T
Profits
200.51B
PE Ratio
49.19
Profit Margin
4.27%
Dividend Yield
0.38%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | -0.46% | 3,730,479 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 651.32B | -0.97% | 8,237,367 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 510.41B | -2.05% | 8,850,081 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 366.03B | -0.78% | 9,095,245 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 359.43B | -1.60% | 5,900,022 | 450.06B |
| 6 | NVS | Novartis AG | 303.18B | 0.45% | 1,546,951 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 288.45B | -0.04% | 2,699,408 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 252.93B | -2.06% | 1,854,077 | 47.35B |
| 9 | AMGN | Amgen Inc. | 251.64B | -0.12% | 3,198,820 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 211.27B | -0.21% | 8,880,192 | 30.99B |
| 11 | ABT | Abbott Laboratories | 190.62B | 3.73% | 8,846,178 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 178.73B | 1.13% | 11,184,323 | 50.34B |
| 13 | PFE | Pfizer Inc. | 174.81B | 0.49% | 50,818,533 | 63.70B |
| 14 | DHR | Danaher Corporation | 160.38B | -1.83% | 3,161,849 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 151.44B | 1.12% | 3,813,372 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 140.20B | -1.03% | 3,212,523 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 128.82B | 0.86% | 10,838,429 | 50.03B |
| 18 | MDT | Medtronic plc | 121.54B | 2.85% | 8,771,478 | 37.54B |
| 19 | SYK | Stryker Corporation | 116.80B | 5.12% | 3,741,485 | 26.30B |
| 20 | MCK | McKesson Corporation | 116.40B | 0.38% | 720,276 | 410.98B |
| 21 | CVS | CVS Health Corporation | 113.20B | -1.93% | 9,698,583 | 412.65B |
| 22 | SNY | Sanofi | 108.20B | 2.73% | 7,384,176 | 57.89B |
| 23 | GSK | GSK plc | 98.15B | -0.77% | 2,654,992 | 44.53B |
| 24 | HCA | HCA Healthcare, Inc. | 97.71B | -1.15% | 1,390,605 | 78.70B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 96.46B | 3.60% | 1,662,856 | 16.90B |
| 26 | ELV | Elevance Health, Inc. | 89.36B | -1.54% | 2,182,766 | 201.83B |
| 27 | MRNA | Moderna, Inc. | 88.16B | -0.40% | 8,453,797 | 2.23B |
| 28 | CI | The Cigna Group | 78.00B | -1.02% | 1,510,911 | 282.38B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 67.28B | -0.19% | 2,650,788 | 29.86B |
| 30 | COR | Cencora, Inc. | 64.47B | 2.12% | 1,506,759 | 332.77B |
| 31 | BSX | Boston Scientific Corporation | 64.23B | 5.57% | 22,714,895 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 58.89B | 1.54% | 1,895,113 | 254.25B |
| 33 | ARGX | argenx SE | 54.92B | -2.00% | 302,249 | 5.92B |
| 34 | NTRA | Natera, Inc. | 54.62B | -8.54% | 2,628,668 | 2.71B |
| 35 | BDX | Becton, Dickinson and Company | 54.10B | 0.36% | 1,785,138 | 22.48B |
| 36 | EW | Edwards Lifesciences Corporation | 53.76B | 1.36% | 12,172,519 | 6.51B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 52.91B | 21.85% | 1,978,076 | 4.66B |
| 38 | VEEV | Veeva Systems Inc. | 49.71B | -1.90% | 1,397,100 | 3.46B |
| 39 | HUM | Humana Inc. | 49.28B | -0.99% | 918,257 | 145.68B |
| 40 | A | Agilent Technologies, Inc. | 48.49B | -1.65% | 1,861,031 | 7.37B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 47.43B | -3.30% | 10,587,241 | 17.32B |
| 42 | MDLN | Medline Inc. | 44.21B | 4.70% | 8,329,820 | 29.94B |
| 43 | WAT | Waters Corporation | 44.17B | -2.85% | 1,943,587 | 4.64B |
| 44 | IQV | IQVIA Holdings Inc. | 42.59B | -3.33% | 1,369,117 | 17.31B |
| 45 | ONC | BeOne Medicines AG | 41.08B | -2.45% | 337,617 | 6.13B |
| 46 | RVMD | Revolution Medicines, Inc. | 40.33B | -1.64% | 1,368,532 | - |
| 47 | RPRX | Royalty Pharma plc | 38.25B | -0.98% | 2,875,918 | 2.54B |
| 48 | HLN | Haleon plc | 38.20B | 1.15% | 34,941,368 | 14.80B |
| 49 | BIIB | Biogen Inc. | 36.81B | -1.82% | 1,174,170 | 10.30B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 35.97B | 3.89% | 4,779,080 | 21.64B |
| 51 | ALC | Alcon Inc. | 35.65B | 3.05% | 2,199,194 | 10.86B |
| 52 | ZTS | Zoetis Inc. | 34.37B | 4.34% | 5,415,050 | 9.53B |
| 53 | ILMN | Illumina, Inc. | 34.26B | -3.99% | 2,928,523 | 4.54B |
| 54 | MTD | Mettler-Toledo International Inc. | 33.63B | 0.20% | 216,940 | 4.13B |
| 55 | GMAB | Genmab A/S | 33.12B | -3.75% | 4,429,405 | 4.13B |
| 56 | CNC | Centene Corporation | 32.94B | -2.80% | 5,631,378 | 180.41B |
| 57 | RMD | ResMed Inc. | 32.76B | 1.30% | 1,601,196 | 5.73B |
| 58 | DXCM | DexCom, Inc. | 31.61B | 3.00% | 4,068,487 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 28.87B | -1.60% | 1,086,366 | 14.59B |
| 60 | WST | West Pharmaceutical Services, Inc. | 28.41B | -1.15% | 1,457,016 | 3.40B |
| 61 | DGX | Quest Diagnostics Incorporated | 27.59B | -0.40% | 996,949 | 11.84B |
| 62 | PHG | Koninklijke Philips N.V. | 26.84B | 2.49% | 2,140,419 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 25.92B | -2.76% | 5,715,257 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 25.57B | -0.43% | 420,379 | 3.15B |
| 65 | INCY | Incyte Corporation | 24.47B | -0.29% | 1,748,977 | 6.01B |
| 66 | INSM | Insmed Incorporated | 23.98B | -2.90% | 4,243,970 | 1.52B |
| 67 | GH | Guardant Health, Inc. | 22.91B | -4.51% | 2,390,363 | 1.18B |
| 68 | STE | STERIS plc | 22.75B | 2.74% | 617,471 | 6.04B |
| 69 | BNTX | BioNTech SE | 21.99B | -0.73% | 710,966 | 3.03B |
| 70 | VTRS | Viatris Inc. | 21.44B | -1.94% | 7,258,079 | 14.74B |
| 71 | THC | Tenet Healthcare Corporation | 21.40B | -1.60% | 1,296,828 | 22.15B |
| 72 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.16B | -4.24% | 4,767,641 | 5.01B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.57B | 2.99% | 2,580,198 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.13B | -0.59% | 198,821 | 2.84B |
| 75 | EXEL | Exelixis, Inc. | 17.11B | 1.07% | 5,574,441 | 2.50B |
| 76 | RVTY | Revvity, Inc. | 16.92B | -3.44% | 2,798,475 | 2.91B |
| 77 | ASND | Ascendis Pharma A/S | 16.35B | -0.91% | 480,125 | 1.20B |
| 78 | CRL | Charles River Laboratories International, Inc. | 16.16B | -5.81% | 1,620,555 | 4.00B |
| 79 | ICLR | ICON Public Limited Company | 15.37B | -2.94% | 779,070 | 8.23B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.77B | -0.51% | 2,021,292 | 3.70B |
| 81 | HALO | Halozyme Therapeutics, Inc. | 14.64B | -1.50% | 3,421,895 | 1.66B |
| 82 | BBIO | BridgeBio Pharma, Inc. | 14.61B | 0.06% | 3,100,583 | 945.54M |
| 83 | SOLV | Solventum Corporation | 14.43B | 4.21% | 1,242,333 | 8.31B |
| 84 | TEM | Tempus AI, Inc. | 14.29B | 8.67% | 17,047,541 | 1.51B |
| 85 | GKOS | Glaukos Corporation | 14.12B | 0.43% | 1,665,232 | 690.33M |
| 86 | JAZZ | Jazz Pharmaceuticals plc | 13.92B | -0.71% | 1,072,201 | 4.72B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 13.80B | -0.94% | 4,692,221 | 15.25B |
| 88 | EHC | Encompass Health Corporation | 13.53B | 0.95% | 1,583,186 | 6.34B |
| 89 | PEN | Penumbra, Inc. | 12.67B | 0.75% | 463,539 | 1.56B |
| 90 | BAX | Baxter International Inc. | 12.53B | 5.30% | 10,163,321 | 11.61B |
| 91 | SNN | Smith & Nephew plc | 12.41B | 1.82% | 1,752,207 | 6.30B |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.04B | 4.51% | 6,539,890 | 5.02B |
| 93 | FMS | Fresenius Medical Care AG | 12.02B | 0.62% | 1,462,428 | 22.19B |
| 94 | SMMT | Summit Therapeutics Inc. | 11.84B | -7.67% | 3,875,001 | - |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.79B | -0.28% | 1,931,962 | 3.44B |
| 96 | DVA | DaVita Inc. | 11.69B | -0.94% | 882,443 | 14.17B |
| 97 | COO | The Cooper Companies, Inc. | 11.66B | 2.94% | 2,439,450 | 4.24B |
| 98 | TECH | Bio-Techne Corporation | 11.40B | 0.01% | 2,020,429 | 1.22B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.12B | -1.83% | 3,267,404 | 3.41B |
| 100 | RGEN | Repligen Corporation | 11.06B | -2.26% | 1,628,609 | 805.61M |
| 101 | ALGN | Align Technology, Inc. | 10.95B | 2.83% | 899,297 | 4.16B |
| 102 | KYMR | Kymera Therapeutics, Inc. | 10.89B | 0.69% | 1,295,620 | 102.24M |
| 103 | MOH | Molina Healthcare, Inc. | 10.86B | 1.79% | 1,269,452 | 42.08B |
| 104 | GMED | Globus Medical, Inc. | 10.67B | 1.81% | 1,512,567 | 3.14B |
| 105 | PODD | Insulet Corporation | 10.65B | 2.63% | 1,773,394 | 3.05B |
| 106 | UHS | Universal Health Services, Inc. | 10.65B | 2.61% | 910,773 | 18.35B |
| 107 | AVTR | Avantor, Inc. | 10.58B | -2.74% | 9,404,223 | 6.64B |
| 108 | QGEN | Qiagen N.V. | 10.41B | 0.26% | 3,572,386 | 2.10B |
| 109 | ENSG | The Ensign Group, Inc. | 10.36B | -1.36% | 408,563 | 5.67B |
| 110 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.96B | 0.18% | 496,143 | 1.28B |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 9.79B | -1.62% | 211,833 | 2.59B |
| 112 | HSIC | Henry Schein, Inc. | 9.65B | 2.05% | 2,503,504 | 13.60B |
| 113 | OSCR | Oscar Health, Inc. | 9.56B | 2.07% | 4,459,356 | 15.32B |
| 114 | PCVX | Vaxcyte, Inc. | 9.54B | -2.27% | 1,322,948 | - |
| 115 | HNGE | Hinge Health, Inc. | 9.32B | 1.01% | 2,313,749 | 800.82M |
| 116 | ATR | AptarGroup, Inc. | 9.12B | 4.85% | 882,426 | 3.99B |
| 117 | CAI | Caris Life Sciences, Inc. | 9.07B | -6.50% | 3,262,868 | 989.61M |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 9.02B | -3.78% | 486,911 | 281.99M |
| 119 | SYRE | Spyre Therapeutics, Inc. | 8.93B | -1.09% | 753,078 | - |
| 120 | KRYS | Krystal Biotech, Inc. | 8.77B | -10.95% | 1,204,956 | 470.03M |
| 121 | CORT | Corcept Therapeutics Incorporated | 8.70B | -0.81% | 1,593,674 | 830.81M |
| 122 | CYTK | Cytokinetics, Incorporated | 8.62B | -1.52% | 1,564,251 | 67.67M |
| 123 | HQY | HealthEquity, Inc. | 8.58B | 1.17% | 991,922 | 1.36B |
| 124 | TGTX | TG Therapeutics, Inc. | 8.50B | -2.01% | 2,580,169 | 799.54M |
| 125 | BRKR | Bruker Corporation | 8.48B | -2.42% | 1,896,374 | 3.50B |
| 126 | IBRX | ImmunityBio, Inc. | 8.43B | -4.10% | 9,073,476 | 165.79M |
| 127 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.41B | -0.55% | 1,315,905 | 669.50M |
| 128 | TWST | Twist Bioscience Corporation | 8.09B | -15.54% | 2,677,560 | 431.80M |
| 129 | TXG | 10x Genomics, Inc. | 8.03B | -12.10% | 5,179,764 | 616.91M |
| 130 | PRAX | Praxis Precision Medicines, Inc. | 7.65B | -4.18% | 312,382 | 7.46M |
| 131 | ALKS | Alkermes plc | 7.53B | -0.99% | 2,164,836 | 1.67B |
| 132 | ABVX | ABIVAX Société Anonyme | 7.43B | -1.94% | 730,991 | 5.33M |
| 133 | GRFS | Grifols, S.A. | 7.35B | 5.06% | 1,590,990 | 8.63B |
| 134 | PACS | PACS Group, Inc. | 7.22B | -4.66% | 874,898 | 5.55B |
| 135 | BLCO | Bausch + Lomb Corporation | 7.15B | 0.05% | 1,508,453 | 5.42B |
| 136 | AXSM | Axsome Therapeutics, Inc. | 7.15B | -5.83% | 2,721,644 | 865.27M |
| 137 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.13B | -1.56% | 999,200 | 945.96M |
| 138 | AMRX | Amneal Pharmaceuticals, Inc. | 7.12B | -4.97% | 5,021,790 | 3.12B |
| 139 | CHE | Chemed Corporation | 7.03B | 1.40% | 125,205 | 2.66B |
| 140 | IONS | Ionis Pharmaceuticals, Inc. | 6.85B | -5.24% | 2,562,688 | 874.09M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.55B | -0.15% | 932,978 | 1.56B |
| 142 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.43B | 0.94% | 2,004,559 | 239.92M |
| 143 | ORKA | Oruka Therapeutics, Inc. | 6.32B | -1.49% | 654,800 | - |
| 144 | BLTE | Belite Bio, Inc | 6.19B | -0.69% | 114,858 | - |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.14B | -4.87% | 265,553 | 253.83M |
| 146 | KOD | Kodiak Sciences Inc. | 6.12B | -1.57% | 595,854 | - |
| 147 | GRAL | GRAIL, Inc. | 5.97B | -6.74% | 983,503 | 165.26M |
| 148 | TFX | Teleflex Incorporated | 5.96B | 0.64% | 923,104 | 2.25B |
| 149 | HIMS | Hims & Hers Health, Inc. | 5.89B | -8.82% | 10,789,504 | 2.58B |
| 150 | IMVT | Immunovant, Inc. | 5.87B | -2.61% | 1,269,358 | - |
| 151 | DOCS | Doximity, Inc. | 5.86B | 0.34% | 1,773,530 | 655.57M |
| 152 | RDNT | RadNet, Inc. | 5.75B | -0.53% | 961,090 | 2.27B |
| 153 | MIRM | Mirum Pharmaceuticals, Inc. | 5.57B | 0.87% | 537,454 | 618.07M |
| 154 | CGON | CG Oncology, Inc. | 5.49B | -4.21% | 1,279,797 | 6.23M |
| 155 | HAE | Haemonetics Corporation | 5.47B | 0.41% | 678,588 | 1.35B |
| 156 | MANE | Veradermics, Incorporated | 5.41B | -7.27% | 636,631 | - |
| 157 | WAY | Waystar Holding Corp. | 5.40B | 0.50% | 2,931,129 | 1.26B |
| 158 | STVN | Stevanato Group S.p.A. | 5.39B | 1.86% | 772,335 | 1.40B |
| 159 | MMED | MiniMed Group, Inc. | 5.32B | 3.39% | 6,761,672 | 3.22B |
| 160 | SRRK | Scholar Rock Holding Corporation | 5.23B | -2.26% | 933,095 | - |
| 161 | BLLN | BillionToOne, Inc. | 5.21B | -2.57% | 636,321 | 397.41M |
| 162 | COGT | Cogent Biosciences, Inc. | 5.16B | -4.16% | 2,000,609 | - |
| 163 | CON | Concentra Group Holdings Parent, Inc. | 5.14B | -0.12% | 1,242,679 | 2.29B |
| 164 | PTCT | PTC Therapeutics, Inc. | 5.09B | 1.52% | 1,340,566 | 1.16B |
| 165 | LFST | LifeStance Health Group, Inc. | 5.07B | -1.04% | 3,370,529 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.06B | -2.26% | 3,190,662 | 1.22B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.05B | -2.24% | 1,205,085 | 1.61B |
| 168 | ERAS | Erasca, Inc. | 4.91B | -2.09% | 4,432,012 | - |
| 169 | CRSP | CRISPR Therapeutics AG | 4.83B | -2.78% | 1,027,355 | 25.17M |
| 170 | OPCH | Option Care Health, Inc. | 4.75B | -0.44% | 2,686,210 | 5.69B |
| 171 | HTFL | HeartFlow, Inc. | 4.74B | -7.72% | 1,648,630 | 212.07M |
| 172 | TVTX | Travere Therapeutics, Inc. | 4.64B | -2.24% | 2,907,311 | 651.03M |
| 173 | DNTH | Dianthus Therapeutics, Inc. | 4.60B | -0.16% | 837,927 | 1.90M |
| 174 | CDNA | CareDx, Inc. | 4.51B | -1.75% | 2,356,878 | 497.40M |
| 175 | LIVN | LivaNova PLC | 4.42B | 1.57% | 606,036 | 1.47B |
| 176 | DFTX | Definium Therapeutics, Inc. | 4.36B | -10.62% | 3,652,456 | - |
| 177 | ITGR | Integer Holdings Corporation | 4.30B | -0.03% | 512,692 | 1.83B |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.28B | 2.57% | 4,872,778 | 1.37B |
| 179 | IRTC | iRhythm Holdings, Inc. | 4.16B | 2.27% | 919,288 | 825.34M |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.14B | -2.03% | 1,085,309 | - |
| 181 | LEGN | Legend Biotech Corporation | 4.09B | -2.45% | 1,135,355 | 1.27B |
| 182 | ICUI | ICU Medical, Inc. | 4.06B | -0.85% | 310,395 | 2.16B |
| 183 | ADPT | Adaptive Biotechnologies Corporation | 4.00B | -5.93% | 2,341,550 | 308.08M |
| 184 | NVST | Envista Holdings Corporation | 3.97B | 5.10% | 4,038,015 | 2.86B |
| 185 | VCYT | Veracyte, Inc. | 3.94B | -2.02% | 1,151,367 | 561.90M |
| 186 | ARQT | Arcutis Biotherapeutics, Inc. | 3.93B | -2.53% | 1,517,094 | 463.98M |
| 187 | RLAY | Relay Therapeutics, Inc. | 3.79B | -5.83% | 2,856,067 | 10.35M |
| 188 | PLSE | Pulse Biosciences, Inc. | 3.77B | 1.26% | 250,722 | 1.19M |
| 189 | LQDA | Liquidia Corporation | 3.75B | -7.12% | 2,591,459 | 450.91M |
| 190 | TNGX | Tango Therapeutics, Inc. | 3.67B | -4.23% | 3,686,720 | 53.81M |
| 191 | XENE | Xenon Pharmaceuticals Inc. | 3.64B | 0.56% | 2,382,384 | 7.50M |
| 192 | IOVA | Iovance Biotherapeutics, Inc. | 3.63B | -5.42% | 21,065,553 | 324.97M |
| 193 | OGN | Organon & Co. | 3.63B | -0.14% | 2,147,315 | 6.10B |
| 194 | ABCL | AbCellera Biologics Inc. | 3.60B | -9.37% | 3,040,656 | 66.17M |
| 195 | ACAD | Acadia Pharmaceuticals Inc. | 3.53B | -0.58% | 1,386,255 | 1.14B |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.52B | -2.84% | 1,163,051 | -665.00K |
| 197 | IRON | Disc Medicine, Inc. | 3.49B | -2.75% | 525,797 | - |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.42B | -1.65% | 4,437,685 | - |
| 199 | PBLS | Parabilis Medicines, Inc. | 3.37B | -3.78% | 703,417 | 148.00K |
| 200 | CELC | Celcuity Inc. | 3.28B | -2.98% | 776,585 | - |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.27B | 0.86% | 1,140,034 | - |
| 202 | DYN | Dyne Therapeutics, Inc. | 3.23B | 3.65% | 2,911,949 | - |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.22B | -2.04% | 429,299 | 606.33M |
| 204 | NHC | National HealthCare Corporation | 3.17B | -1.96% | 165,066 | 1.56B |
| 205 | RGC | Regencell Bioscience Holdings Limited | 3.12B | -6.26% | 76,403 | - |
| 206 | TLX | Telix Pharmaceuticals Limited | 3.10B | -0.55% | 258,307 | 890.79M |
| 207 | IDYA | IDEAYA Biosciences, Inc. | 3.05B | -1.00% | 790,578 | 234.13M |
| 208 | ATRC | AtriCure, Inc. | 3.05B | -2.24% | 1,124,148 | 569.62M |
| 209 | DNLI | Denali Therapeutics Inc. | 3.01B | -0.42% | 1,236,670 | 3.60M |
| 210 | BHC | Bausch Health Companies Inc. | 3.00B | -2.20% | 4,943,344 | 11.11B |
| 211 | SGRY | Surgery Partners, Inc. | 3.00B | -0.39% | 3,400,520 | 3.37B |
| 212 | AXGN | Axogen, Inc. | 2.98B | 0.97% | 1,962,734 | 266.93M |
| 213 | WRBY | Warby Parker Inc. | 2.95B | -3.05% | 3,771,394 | 911.61M |
| 214 | VRDN | Viridian Therapeutics, Inc. | 2.87B | 2.55% | 3,398,316 | 71.13M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.86B | -0.30% | 3,016,038 | 2.60B |
| 216 | NRIX | Nurix Therapeutics, Inc. | 2.81B | -4.10% | 2,350,062 | 701.94M |
| 217 | ACHC | Acadia Healthcare Company, Inc. | 2.76B | -1.13% | 1,257,947 | 3.37B |
| 218 | PRVA | Privia Health Group, Inc. | 2.72B | -0.93% | 1,165,818 | 2.36B |
| 219 | ZLAB | Zai Lab Limited | 2.69B | -1.84% | 474,409 | 449.61M |
| 220 | MBX | MBX Biosciences, Inc. | 2.62B | -2.63% | 327,132 | - |
| 221 | BEAM | Beam Therapeutics Inc. | 2.59B | -4.99% | 1,449,334 | 156.04M |
| 222 | NEOG | Neogen Corporation | 2.58B | - | 2,801,751 | 884.00M |
| 223 | RCUS | Arcus Biosciences, Inc. | 2.57B | -1.87% | 1,380,503 | 117.00M |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.53B | -1.70% | 410,299 | 1.46B |
| 225 | BKD | Brookdale Senior Living Inc. | 2.49B | 0.48% | 5,472,403 | 2.93B |
| 226 | ADMA | ADMA Biologics, Inc. | 2.48B | -3.07% | 2,894,665 | 512.28M |
| 227 | SUPN | Supernus Pharmaceuticals, Inc. | 2.44B | - | - | 865.11M |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.36B | 1.37% | 596,031 | 1.10B |
| 229 | PHVS | Pharvaris N.V. | 2.35B | - | 610,604 | - |
| 230 | HCM | HUTCHMED (China) Limited | 2.34B | 0.91% | 48,003 | 549.12M |
| 231 | MD | Pediatrix Medical Group, Inc. | 2.34B | 2.98% | 1,171,049 | 1.96B |
| 232 | NAMS | NewAmsterdam Pharma Company N.V. | 2.34B | -2.49% | 2,008,527 | 7.12M |
| 233 | TMDX | TransMedics Group, Inc. | 2.31B | 1.03% | 690,018 | 668.47M |
| 234 | IMNM | Immunome, Inc. | 2.31B | 7.58% | 2,288,904 | 4.02M |
| 235 | ADUS | Addus HomeCare Corporation | 2.30B | 0.17% | 509,821 | 1.48B |
| 236 | BHVN | Biohaven Ltd. | 2.29B | -1.69% | 2,592,265 | - |
| 237 | RXRX | Recursion Pharmaceuticals, Inc. | 2.29B | -4.96% | 22,593,996 | 68.23M |
| 238 | CLOV | Clover Health Investments, Corp. | 2.29B | -3.36% | 5,015,002 | 2.48B |
| 239 | CLDX | Celldex Therapeutics, Inc. | 2.28B | -3.52% | 957,238 | 158.00K |
| 240 | PGNY | Progyny, Inc. | 2.26B | 0.75% | 1,352,559 | 1.31B |
| 241 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | -2.19% | 994,475 | 959.90M |
| 242 | XNCR | Xencor, Inc. | 2.21B | -0.54% | 2,107,665 | 104.97M |
| 243 | UFPT | UFP Technologies, Inc. | 2.20B | -0.19% | 85,578 | 631.64M |
| 244 | PRGO | Perrigo Company plc | 2.19B | -0.19% | 2,007,452 | 4.14B |
| 245 | VERA | Vera Therapeutics, Inc. | 2.18B | -2.36% | 2,113,400 | - |
| 246 | AUPH | Aurinia Pharmaceuticals Inc. | 2.16B | -3.06% | 1,615,773 | 321.74M |
| 247 | TRLV | Trulieve Cannabis Corp. | 2.14B | 7.98% | 1,987,415 | 1.14B |
| 248 | NEO | NeoGenomics, Inc. | 2.13B | -5.12% | 1,707,890 | 787.75M |
| 249 | PVLA | Palvella Therapeutics, Inc. | 2.11B | 0.12% | 303,601 | - |
| 250 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.11B | -2.66% | 4,096,742 | 940.61M |
| 251 | VCEL | Vericel Corporation | 2.07B | 0.62% | 685,545 | 306.30M |
| 252 | ZYME | Zymeworks Inc. | 2.06B | 1.33% | 1,177,361 | 37.13M |
| 253 | LKFT | Lakefront Biotherapeutics NV | 2.04B | -0.81% | 259,521 | 1.13B |
| 254 | SEPN | Septerna, Inc. | 2.02B | -1.82% | 475,997 | 98.88M |
| 255 | ALMR | Alamar Biosciences, Inc. | 2.01B | -5.42% | 877,209 | 100.42M |
| 256 | XRAY | DENTSPLY SIRONA Inc. | 1.97B | 3.88% | 6,073,159 | 3.64B |
| 257 | MESO | Mesoblast Limited | 1.97B | -4.09% | 261,719 | 120.25M |
| 258 | SDGR | Schrödinger, Inc. | 1.96B | -3.50% | 1,394,291 | 259.04M |
| 259 | INSP | Inspire Medical Systems, Inc. | 1.94B | -1.31% | 1,075,927 | 880.94M |
| 260 | TRVI | Trevi Therapeutics, Inc. | 1.94B | 0.52% | 1,474,155 | - |
| 261 | SRPT | Sarepta Therapeutics, Inc. | 1.94B | -1.61% | 1,163,639 | 1.97B |
| 262 | FTRE | Fortrea Holdings Inc. | 1.93B | -5.97% | 1,754,330 | 2.67B |
| 263 | COAG | Hemab Therapeutics Holdings, Inc. | 1.92B | -0.65% | 344,404 | - |
| 264 | WGS | GeneDx Holdings Corp. | 1.91B | -7.20% | 927,628 | 454.43M |
| 265 | TRAX | First Tracks Biotherapeutics, Inc. | 1.89B | -0.07% | 426,915 | - |
| 266 | ASTH | Astrana Health, Inc. | 1.89B | 0.96% | 275,993 | 3.84B |
| 267 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | -7.94% | 2,295,917 | 208.78M |
| 268 | VIR | Vir Biotechnology, Inc. | 1.86B | -2.65% | 1,379,837 | 303.23M |
| 269 | LMAT | LeMaitre Vascular, Inc. | 1.86B | 0.40% | 270,593 | 262.43M |
| 270 | XERS | Xeris Biopharma Holdings, Inc. | 1.85B | -5.04% | 2,311,817 | 335.41M |
| 271 | REPL | Replimune Group, Inc. | 1.85B | 10.68% | 7,731,953 | - |
| 272 | PGEN | Precigen, Inc. | 1.84B | -25.94% | 20,657,836 | 85.72M |
| 273 | ESTA | Establishment Labs Holdings Inc. | 1.82B | -2.23% | 709,350 | 264.03M |
| 274 | ZBIO | Zenas BioPharma, Inc. | 1.80B | -2.71% | 408,888 | 1.00M |
| 275 | AGIO | Agios Pharmaceuticals, Inc. | 1.79B | -1.96% | 1,913,942 | 98.34M |
| 276 | KMTS | Kestra Medical Technologies, Ltd. | 1.78B | 0.40% | 412,948 | 106.73M |
| 277 | AMN | AMN Healthcare Services, Inc. | 1.77B | -2.84% | 977,287 | 3.43B |
| 278 | ADRX | ADARx Pharmaceuticals, Inc. | 1.77B | -7.29% | 379,579 | 6.13M |
| 279 | HCSG | Healthcare Services Group, Inc. | 1.74B | 5.06% | 672,723 | 1.88B |
| 280 | SLS | SELLAS Life Sciences Group, Inc. | 1.73B | -11.67% | 14,440,222 | - |
| 281 | BRVE | Braveheart Bio, Inc. | 1.72B | -2.19% | 260,311 | - |
| 282 | STOK | Stoke Therapeutics, Inc. | 1.72B | 0.72% | 1,405,990 | 28.21M |
| 283 | GENB | Generate Biomedicines, Inc. | 1.70B | -8.64% | 746,083 | 26.48M |
| 284 | PSNL | Personalis, Inc. | 1.68B | -0.38% | 2,207,184 | 69.67M |
| 285 | URGN | UroGen Pharma Ltd. | 1.68B | 5.01% | 2,040,753 | 188.73M |
| 286 | ABSI | Absci Corporation | 1.66B | -12.94% | 3,817,461 | 1.56M |
| 287 | OMCL | Omnicell, Inc. | 1.66B | -0.65% | 1,079,329 | 1.24B |
| 288 | ARDT | Ardent Health, Inc. | 1.65B | -2.49% | 368,250 | 6.41B |
| 289 | BFLY | Butterfly Network, Inc. | 1.64B | -3.91% | 5,251,208 | 123.26M |
| 290 | MAZE | Maze Therapeutics, Inc. | 1.64B | -3.53% | 331,700 | 20.00M |
| 291 | NTLA | Intellia Therapeutics, Inc. | 1.63B | -6.50% | 3,888,785 | 59.51M |
| 292 | CERT | Certara, Inc. | 1.63B | -2.81% | 1,953,771 | 421.75M |
| 293 | NUVB | Nuvation Bio Inc. | 1.61B | -3.57% | 3,723,422 | 169.90M |
| 294 | SNDA | Sonida Senior Living, Inc. | 1.60B | -1.25% | 399,902 | 481.07M |
| 295 | RARE | Ultragenyx Pharmaceutical Inc. | 1.60B | 1.24% | 4,845,655 | 717.00M |
| 296 | ALVO | Alvotech | 1.60B | -3.66% | 1,555,108 | 494.61M |
| 297 | QURE | uniQure N.V. | 1.59B | -7.49% | 6,452,788 | 18.67M |
| 298 | KLRA | Kailera Therapeutics, Inc. | 1.58B | -5.52% | 882,842 | - |
| 299 | TDOC | Teladoc Health, Inc. | 1.57B | 1.41% | 6,065,925 | 2.47B |
| 300 | PAHC | Phibro Animal Health Corporation | 1.57B | -0.36% | 250,912 | 1.52B |
| 301 | NVAX | Novavax, Inc. | 1.57B | -5.46% | 4,093,391 | 413.80M |
| 302 | LYCA | Lycia Therapeutics, Inc. | 1.57B | 2.95% | 271,002 | 4.44M |
| 303 | AZTA | Azenta, Inc. | 1.56B | -8.99% | 958,794 | 613.81M |
| 304 | NVCR | NovoCure Limited | 1.54B | 0.46% | 1,648,718 | 725.39M |
| 305 | IMCR | Immunocore Holdings plc | 1.53B | -2.30% | 226,587 | 430.78M |
| 306 | INVA | Innoviva, Inc. | 1.52B | -0.94% | 1,121,757 | 440.00M |
| 307 | ANIP | ANI Pharmaceuticals, Inc. | 1.51B | -1.85% | 515,280 | 978.38M |
| 308 | RAPP | Rapport Therapeutics, Inc. | 1.49B | 0.32% | 1,330,024 | 20.00M |
| 309 | OCUL | Ocular Therapeutix, Inc. | 1.48B | -3.44% | 1,885,358 | 52.06M |
| 310 | TYRA | Tyra Biosciences, Inc. | 1.47B | 1.23% | 540,527 | - |
| 311 | ALHC | Alignment Healthcare, Inc. | 1.46B | -3.71% | 6,871,895 | 4.94B |
| 312 | GPCR | Structure Therapeutics Inc. | 1.46B | -6.40% | 789,391 | - |
| 313 | AGL | agilon health, inc. | 1.45B | 2.04% | 281,533 | 5.92B |
| 314 | ETON | Eton Pharmaceuticals, Inc. | 1.45B | -2.63% | 557,734 | 105.60M |
| 315 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.03% | 811,170 | 746.16M |
| 316 | KRSA | Korsana Biosciences, Inc. | 1.44B | 5.04% | 197,545 | - |
| 317 | NBTX | Nanobiotix S.A. | 1.44B | -10.39% | 119,350 | 13.15M |
| 318 | PNTG | The Pennant Group, Inc. | 1.41B | -2.78% | 314,900 | 1.10B |
| 319 | GHRS | GH Research PLC | 1.41B | -1.73% | 543,067 | - |
| 320 | ANAB | AnaptysBio, Inc. | 1.40B | -2.84% | 282,040 | 106.09M |
| 321 | CNMD | CONMED Corporation | 1.39B | 5.19% | 444,221 | 1.37B |
| 322 | MLYS | Mineralys Therapeutics, Inc. | 1.37B | -14.47% | 4,596,950 | - |
| 323 | DMRA | Damora Therapeutics, Inc. | 1.33B | 0.51% | 497,360 | - |
| 324 | KARD | Kardigan, Inc. | 1.33B | 0.57% | 462,842 | - |
| 325 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | -3.15% | 2,009,687 | 5.49M |
| 326 | TNDM | Tandem Diabetes Care, Inc. | 1.30B | -2.30% | 2,904,288 | 1.04B |
| 327 | OMER | Omeros Corporation | 1.29B | -3.31% | 904,127 | 38.42M |
| 328 | OPK | OPKO Health, Inc. | 1.28B | 3.61% | 3,085,227 | 587.90M |
| 329 | NUTX | Nutex Health Inc. | 1.27B | -7.27% | 258,413 | 846.72M |
| 330 | USPH | U.S. Physical Therapy, Inc. | 1.27B | -1.08% | 334,713 | 804.27M |
| 331 | NKTR | Nektar Therapeutics | 1.26B | -4.94% | 824,531 | 54.59M |
| 332 | LBRX | LB Pharmaceuticals Inc | 1.26B | -1.66% | 466,622 | - |
| 333 | AAPG | Ascentage Pharma Group International | 1.26B | -6.22% | 5,523 | 94.61M |
| 334 | STAA | STAAR Surgical Company | 1.25B | 1.63% | 706,268 | 339.59M |
| 335 | FRNM | Freenome, Inc. | 1.25B | -6.97% | 686,104 | 35.41M |
| 336 | CRON | Cronos Group Inc. | 1.24B | 0.91% | 1,015,433 | 179.09M |
| 337 | INNV | InnovAge Holding Corp. | 1.22B | -2.94% | 535,862 | 989.71M |
| 338 | GDRX | GoodRx Holdings, Inc. | 1.21B | 1.72% | 1,170,085 | 785.23M |
| 339 | SVRA | Savara Inc. | 1.20B | -1.87% | 1,780,241 | - |
| 340 | SLN | Silence Therapeutics plc | 1.19B | 0.05% | 1,188,307 | 615.00K |
| 341 | ENOV | Enovis Corporation | 1.19B | 3.57% | 2,493,216 | 2.30B |
| 342 | DRTS | Alpha Tau Medical Ltd. | 1.18B | -1.76% | 437,363 | - |
| 343 | VOR | Vor Biopharma Inc. | 1.18B | -2.18% | 624,745 | - |
| 344 | MNKD | MannKind Corporation | 1.17B | 4.29% | 3,188,703 | 393.63M |
| 345 | SNDX | Syndax Pharmaceuticals, Inc. | 1.17B | -4.03% | 3,180,376 | 289.68M |
| 346 | VSTM | Verastem, Inc. | 1.17B | -1.64% | 2,118,091 | 87.53M |
| 347 | CMPS | COMPASS Pathways plc | 1.16B | -27.31% | 16,869,245 | - |
| 348 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.15B | -2.49% | 498,425 | 730.02M |
| 349 | AORT | Artivion, Inc. | 1.15B | 4.43% | 626,161 | 471.47M |
| 350 | AVLN | Avalyn Pharma Inc. | 1.13B | -0.12% | 445,533 | - |
| 351 | ATEC | Alphatec Holdings, Inc. | 1.13B | 3.84% | 14,223,722 | 839.72M |
| 352 | SGP | SpyGlass Pharma, Inc. | 1.13B | 4.34% | 94,879 | - |
| 353 | AHG | Akso Health Group | 1.12B | 4.17% | 2,949 | 13.83M |
| 354 | PRCT | PROCEPT BioRobotics Corporation | 1.11B | 1.25% | 1,274,728 | 337.34M |
| 355 | BVS | Bioventus Inc. | 1.11B | -1.35% | 682,426 | 585.64M |
| 356 | OMDA | Omada Health, Inc. | 1.09B | -4.70% | 949,258 | 309.76M |
| 357 | LMRI | Lumexa Imaging Holdings, Inc. | 1.07B | -2.28% | 293,850 | 1.04B |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.07B | 2.09% | 528,212 | - |
| 359 | JANX | Janux Therapeutics, Inc. | 1.07B | -0.06% | 412,936 | 24.00M |
| 360 | CSTL | Castle Biosciences, Inc. | 1.07B | -5.97% | 470,989 | 357.28M |
| 361 | INBX | Inhibrx Biosciences, Inc. | 1.06B | 0.53% | 234,873 | 1.30M |
| 362 | IART | Integra LifeSciences Holdings Corporation | 1.06B | 6.75% | 1,506,317 | 1.66B |
| 363 | HSTM | HealthStream, Inc. | 1.06B | 2.61% | 282,100 | 327.95M |
| 364 | HROW | Harrow, Inc. | 1.06B | -0.14% | 743,493 | 275.59M |
| 365 | CTY | City Therapeutics, Inc. | 1.04B | 0.82% | 224,678 | 14.34M |
| 366 | CBLL | CeriBell, Inc. | 1.03B | 1.43% | 912,901 | 101.96M |
| 367 | IRMD | IRADIMED CORPORATION | 1.02B | 3.57% | 203,773 | 89.34M |
| 368 | MLTX | MoonLake Immunotherapeutics | 976.17M | -2.63% | 973,430 | - |
| 369 | IMTX | Immatics N.V. | 965.03M | -1.94% | 1,025,241 | 47.65M |
| 370 | QDEL | QuidelOrtho Corporation | 962.11M | 5.89% | 2,863,167 | 2.67B |
| 371 | CGEM | Cullinan Therapeutics, Inc. | 960.82M | -0.67% | 731,485 | - |
| 372 | RIGL | Rigel Pharmaceuticals, Inc. | 943.89M | -1.52% | 136,040 | 276.79M |
| 373 | ORIC | ORIC Pharmaceuticals, Inc. | 940.13M | -1.84% | 1,924,891 | - |
| 374 | ODTX | Odyssey Therapeutics, Inc. | 935.85M | -0.05% | 259,119 | 99.00K |
| 375 | GLUE | Monte Rosa Therapeutics, Inc. | 906.88M | -1.21% | 1,769,973 | 28.73M |
| 376 | SIBN | SI-BONE, Inc. | 906.23M | -4.76% | 1,374,332 | 220.65M |
| 377 | LTGO | Latigo Biotherapeutics, Inc. | 895.70M | -3.15% | 290,901 | - |
| 378 | MGTX | MeiraGTx Holdings plc | 895.12M | -1.79% | 580,601 | 397.50M |
| 379 | OBX | Obsidian Therapeutics, Inc. | 891.38M | -2.43% | 526,999 | - |
| 380 | PHAR | Pharming Group N.V. | 889.88M | 4.09% | 19,943 | 386.75M |
| 381 | JBIO | Jade Biosciences, Inc. | 885.91M | -0.92% | 718,998 | - |
| 382 | KURA | Kura Oncology, Inc. | 870.92M | -4.58% | 1,725,373 | 77.23M |
| 383 | ANRO | Alto Neuroscience, Inc. | 870.78M | -1.81% | 473,279 | - |
| 384 | BBNX | Beta Bionics, Inc. | 864.44M | -5.07% | 805,001 | 127.27M |
| 385 | GMRS | GMR Solutions Inc. | 863.49M | -0.71% | 863,520 | 5.88B |
| 386 | IVA | Inventiva S.A. | 853.50M | 4.93% | 3,250,958 | 2.81M |
| 387 | ALMS | Alumis Inc. | 825.80M | -5.20% | 1,431,849 | 7.40M |
| 388 | CRVS | Corvus Pharmaceuticals, Inc. | 815.97M | -3.29% | 610,053 | - |
| 389 | BBTX | Bambusa Therapeutics, Inc. | 815.08M | 6.74% | 434,330 | - |
| 390 | AKTS | Aktis Oncology, Inc. | 811.49M | -8.41% | 898,781 | 10.06M |
| 391 | KIDS | OrthoPediatrics Corp. | 794.54M | -1.43% | 489,279 | 264.14M |
| 392 | ABUS | Arbutus Biopharma Corporation | 791.39M | -4.99% | 2,655,095 | 181.72M |
| 393 | PRME | Prime Medicine, Inc. | 789.90M | -5.93% | 4,133,252 | 4.07M |
| 394 | AHCO | AdaptHealth Corp. | 788.45M | 1.72% | 3,044,510 | 3.36B |
| 395 | INMD | InMode Ltd. | 787.49M | 3.63% | 1,114,657 | 374.63M |
| 396 | VREX | Varex Imaging Corporation | 778.05M | 0.16% | 903,720 | 865.00M |
| 397 | PHR | Phreesia, Inc. | 772.16M | - | 662,338 | 507.79M |
| 398 | COLL | Collegium Pharmaceutical, Inc. | 770.92M | -0.50% | 602,404 | 808.21M |
| 399 | ARDX | Ardelyx, Inc. | 755.04M | - | 4,618,397 | 450.89M |
| 400 | CTKB | Cytek Biosciences, Inc. | 750.00M | -5.87% | 1,543,961 | 206.71M |
| 401 | ANNX | Annexon, Inc. | 746.94M | -2.72% | 2,279,336 | - |
| 402 | OABI | OmniAb, Inc. | 742.43M | -0.39% | 2,150,166 | 40.21M |
| 403 | PACB | Pacific Biosciences of California, Inc. | 728.90M | -9.98% | 9,106,551 | 159.27M |
| 404 | SLBT | SL Science Holding Limited | 724.24M | 5.83% | 15,616 | 3.27M |
| 405 | SANA | Sana Biotechnology, Inc. | 718.47M | -6.61% | 2,597,932 | - |
| 406 | WVE | Wave Life Sciences, Inc. | 694.25M | -1.95% | 1,942,429 | 70.92M |
| 407 | SGMT | Sagimet Biosciences Inc. | 687.10M | -2.32% | 737,428 | - |
| 408 | ATTO | Attovia Therapeutics, Inc. | 687.05M | -0.92% | 154,905 | 1.80M |
| 409 | ACHV | Achieve Life Sciences, Inc. | 680.19M | -3.22% | 1,532,927 | - |
| 410 | DNA | Ginkgo Bioworks Holdings, Inc. | 663.30M | -12.13% | 3,550,697 | 132.42M |
| 411 | AVBP | ArriVent BioPharma, Inc. | 658.26M | -10.22% | 1,240,175 | - |
| 412 | SLDB | Solid Biosciences Inc. | 643.35M | -3.23% | 1,131,081 | - |
| 413 | HELP | Helus Pharma Inc. | 642.93M | -16.98% | 3,891,294 | - |
| 414 | APMD | Apnimed, Inc. | 641.11M | -6.10% | 531,708 | 115.12M |
| 415 | LXRX | Lexicon Pharmaceuticals, Inc. | 640.74M | 1.41% | 2,023,255 | 41.47M |
| 416 | STLN | Starling Oncology, Inc. | 636.98M | -4.29% | 1,464,410 | 587.24M |
| 417 | DSGN | Design Therapeutics, Inc. | 635.20M | -4.96% | 288,618 | - |
| 418 | FDMT | 4D Molecular Therapeutics, Inc. | 628.13M | -4.45% | 735,577 | 92.01M |
| 419 | AURA | Aura Biosciences, Inc. | 625.34M | -1.79% | 747,077 | - |
| 420 | NVCT | Nuvectis Pharma, Inc. | 624.91M | 3.79% | 213,645 | - |
| 421 | CADL | Candel Therapeutics, Inc. | 621.33M | -2.52% | 862,746 | - |
| 422 | OLMA | Olema Pharmaceuticals, Inc. | 618.61M | 1.00% | 1,119,414 | - |
| 423 | IAM | Iambic Therapeutics, Inc. | 614.08M | -3.54% | 403,052 | 18.25M |
| 424 | SOPH | SOPHiA GENETICS SA | 605.26M | -6.82% | 407,280 | 86.17M |
| 425 | ANL | Adlai Nortye Group Ltd. | 603.41M | -1.88% | 272,824 | 18.06M |
| 426 | IMMX | Immix Biopharma, Inc. | 601.88M | -5.47% | 1,508,292 | - |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 599.78M | -1.75% | 638,272 | 136.07M |
| 428 | GERN | Geron Corporation | 596.92M | 3.88% | 13,809,251 | 204.56M |
| 429 | ACRS | Aclaris Therapeutics, Inc. | 588.94M | -4.28% | 1,645,974 | 8.22M |
| 430 | DBVT | DBV Technologies S.A. | 572.94M | -4.64% | 207,561 | 3.74M |
| 431 | IRWD | Ironwood Pharmaceuticals, Inc. | 571.73M | -1.14% | 1,302,696 | 389.32M |
| 432 | AVR | Anteris Technologies Global Corp. | 563.51M | -8.40% | 4,023,185 | 2.24M |
| 433 | MYGN | Myriad Genetics, Inc. | 559.55M | -7.87% | 1,347,333 | 806.60M |
| 434 | CLYM | Climb Bio, Inc. | 559.43M | -4.98% | 1,148,898 | - |
| 435 | EVO | Evotec SE | 559.05M | -0.65% | 67,656 | 819.47M |
| 436 | CBIO | Crescent Biopharma, Inc. | 552.56M | -4.23% | 147,333 | 11.88M |
| 437 | INDP | Indaptus Therapeutics, Inc. | 537.53M | 13.27% | 226,654 | - |
| 438 | ENTX | Entera Bio Ltd. | 537.42M | -3.44% | 330,540 | 42.00K |
| 439 | STTK | Shattuck Labs, Inc. | 533.93M | -4.32% | 652,646 | 1.00M |
| 440 | NGNE | Neurogene Inc. | 532.50M | -3.41% | 173,832 | 925.00K |
| 441 | FLGT | Fulgent Genetics, Inc. | 530.77M | -6.45% | 339,602 | 323.93M |
| 442 | PBYI | Puma Biotechnology, Inc. | 525.49M | -2.49% | 399,568 | 231.24M |
| 443 | BCAX | Bicara Therapeutics Inc. | 524.75M | -13.14% | 2,506,789 | - |
| 444 | TCMD | Tactile Systems Technology, Inc. | 518.06M | -0.74% | 245,603 | 356.42M |
| 445 | NRC | NRC Health | 514.83M | 1.80% | 101,205 | 143.79M |
| 446 | SRZN | Surrozen, Inc. | 507.71M | -0.07% | 159,648 | 11.51M |
| 447 | VALN | Valneva SE | 505.13M | -2.39% | 7,430 | 163.30M |
| 448 | MCTA | Charming Medical Limited | 504.26M | -0.02% | - | 4.81M |
| 449 | SGHT | Sight Sciences, Inc. | 504.06M | -1.82% | 227,221 | 83.38M |
| 450 | EVH | Evolent Health, Inc. | 503.11M | 3.49% | 1,430,307 | 2.10B |
| 451 | GYRE | Gyre Therapeutics, Inc. | 501.54M | 3.84% | 390,018 | 109.82M |
| 452 | DMAC | DiaMedica Therapeutics Inc. | 500.97M | 0.43% | 141,711 | - |
| 453 | FTH | Faeth Therapeutics, Inc. | 496.91M | 2.89% | 213,205 | - |
| 454 | DCTH | Delcath Systems, Inc. | 495.85M | 1.78% | 365,399 | 95.42M |
| 455 | ANGO | AngioDynamics, Inc. | 494.56M | -1.92% | 458,450 | 325.38M |
| 456 | ARVN | Arvinas, Inc. | 491.70M | -4.33% | 1,145,352 | 316.70M |
| 457 | CTMX | CytomX Therapeutics, Inc. | 485.92M | -4.70% | 9,488,749 | 18.30M |
| 458 | MDXG | MiMedx Group, Inc. | 478.64M | -15.46% | 2,565,332 | 303.73M |
| 459 | RCEL | AVITA Medical, Inc. | 476.58M | -1.53% | 492,231 | 75.63M |
| 460 | OCS | Oculis Holding AG | 475.95M | -6.66% | 246,685 | 1.45M |
| 461 | CERS | Cerus Corporation | 475.60M | 3.51% | 3,989,782 | 226.57M |
| 462 | SENS | Senseonics Holdings, Inc. | 474.81M | -5.57% | 573,881 | 48.55M |
| 463 | AQST | Aquestive Therapeutics, Inc. | 473.18M | -3.08% | 2,636,919 | 54.09M |
| 464 | EOLS | Evolus, Inc. | 472.92M | -2.59% | 717,329 | 316.49M |
| 465 | RGNX | REGENXBIO Inc. | 472.65M | -0.56% | 1,029,828 | 174.48M |
| 466 | PHAT | Phathom Pharmaceuticals, Inc. | 469.83M | 3.05% | 2,818,199 | 274.88M |
| 467 | OVID | Ovid Therapeutics Inc. | 466.76M | -5.91% | 2,371,321 | 1.58M |
| 468 | SSII | SS Innovations International, Inc. | 462.89M | -1.70% | 84,967 | 52.40M |
| 469 | ETRA | Electra Therapeutics, Inc. | 458.83M | -9.75% | 385,639 | - |
| 470 | BWAY | BrainsWay Ltd. | 448.58M | -2.38% | 77,634 | 60.70M |
| 471 | MNPR | Monopar Therapeutics Inc. | 444.88M | -5.75% | 219,368 | - |
| 472 | EPRX | Eupraxia Pharmaceuticals Inc. | 441.97M | -1.02% | 344,959 | - |
| 473 | TKNO | Alpha Teknova, Inc. | 432.53M | -4.76% | 517,879 | 43.70M |
| 474 | PRTA | Prothena Corporation plc | 425.58M | -2.13% | 464,594 | 54.53M |
| 475 | NPCE | NeuroPace, Inc. | 423.56M | 0.33% | 120,656 | 106.99M |
| 476 | YDES | YD Bio Limited | 422.86M | 0.51% | 180,501 | 1.24M |
| 477 | KMDA | Kamada Ltd. | 422.62M | -4.42% | 168,996 | 191.85M |
| 478 | MASS | 908 Devices Inc. | 422.02M | -9.24% | 444,745 | 60.84M |
| 479 | CAPR | Capricor Therapeutics, Inc. | 420.93M | 13.48% | 5,037,485 | 11.13M |
| 480 | CRMD | CorMedix Inc. | 420.12M | -5.44% | 3,312,251 | 462.25M |
| 481 | CARL | Carlsmed, Inc. | 410.09M | 0.47% | 93,739 | 63.30M |
| 482 | RLMD | Relmada Therapeutics, Inc. | 409.61M | 7.26% | 2,260,825 | - |
| 483 | RZLT | Rezolute, Inc. | 407.00M | -1.77% | 847,153 | - |
| 484 | SI | Shoulder Innovations, Inc. | 402.22M | 0.99% | 65,507 | 60.06M |
| 485 | ASMB | Assembly Biosciences, Inc. | 397.24M | -3.08% | 263,437 | 74.85M |
| 486 | PRLD | Prelude Therapeutics Incorporated | 395.50M | -1.03% | 216,967 | 22.42M |
| 487 | CCCC | C4 Therapeutics, Inc. | 394.91M | -4.75% | 2,863,844 | 35.04M |
| 488 | BLSM | BlossomHill Therapeutics, Inc. | 394.77M | -9.67% | 140,982 | - |
| 489 | EDIT | Editas Medicine, Inc. | 394.70M | -3.75% | 1,238,112 | 47.01M |
| 490 | ALT | Altimmune, Inc. | 392.93M | -0.98% | 2,742,160 | 31.00K |
| 491 | AVTX | Avalo Therapeutics, Inc. | 392.57M | 2.09% | 1,621,072 | 59.00K |
| 492 | CTEV | Claritev Corporation | 388.44M | -4.50% | 163,854 | 994.67M |
| 493 | ZURA | Zura Bio Limited | 379.52M | -2.48% | 3,727,469 | - |
| 494 | ASPE | Aspen Neuroscience, Inc. | 379.18M | -12.42% | 596,671 | - |
| 495 | SRTA | Strata Critical Medical, Inc. | 378.64M | -3.60% | 2,262,099 | 255.98M |
| 496 | AUTL | Autolus Therapeutics plc | 377.95M | -6.58% | 4,706,476 | 117.39M |
| 497 | MPLT | MapLight Therapeutics, Inc. | 376.80M | -10.55% | 245,685 | - |
| 498 | ALLO | Allogene Therapeutics, Inc. | 376.59M | -7.63% | 10,063,993 | 4.64M |
| 499 | TLRY | Tilray Brands, Inc. | 373.99M | 0.79% | 4,618,872 | 963.10M |
| 500 | TECX | Tectonic Therapeutic, Inc. | 371.05M | -4.04% | 184,219 | - |